5604 results
Refine Your Search
Alana
My name is Alana, and I’m years old. Here is my story. On June , , I was out having dinner with my family, and my smartwatch told me that my heart ra…
Targeted combination therapies for leukemia with NUP98 translocations
Leukemia patients with chromosomal translocations of the Nucleoporin (NUP98) gene suffer from very poor prognosis. In this project we will identify ne…
Joachim Yahalom
MD- Hebrew University, Jerusalem. Residencies and Fellowships in Clinical and radiation Oncology in Israel and Memorial . Armored Brigade Physician (M…
Impact of sublethal radiation dose on tumor response, microenvironment and the immune system
Extremely low dose radiation can improve blood cancer outcomes. But the mechanisms of how sublethal radiation (SRT) affects tumors, the microenvironme…
Suzanne Lentzsch
I’m a Professor of Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at Columbia University. I received my medical and doctora…
Targeting the MMP-13/PD-1H signaling axis for multiple myeloma bone disease and immunosuppression
Multiple myeloma is an incurable blood cancer complicated by bone diseases and compromised immune system. Our work indicated that checkpoint inhibitor…
LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling
LLS Remains Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling
Advocacy
Jane Oliaro
Professor Jane Oliaro is an internationally recognized cancer immunologist motivated to translate scientific discoveries into the clinic.
Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma
Despite the promise of cell immunotherapy for patients with lymphoma and multiple myeloma, a significant proportion of patients fail to respond or re…
Kirk Schultz
Dr. Kirk Schultz is a Professor at the University of British Columbia, BC Children’s Hospital Research Institute, and an elected fellow of the Canadia…
A Polyomic Approach to Chronic Graft-versus-Host Disease (cGvHD) Biomarkers in Adults
Our team is the first to develop a polyomic pediatric cGvHD biomarker test for assessing the risk of developing cGvHD. A cooperative adult phase III c…
Marco Ruella
Dr. Marco Ruella is a and assistant professor at the University of Pennsylvania. He treats patients with blood cancers and focuses on using immunothe…
Anti-Sox2 immunotherapy to prevent multiple myeloma relapse
Advances in multiple myeloma (MM) therapy have improved survival, but serial cycles of response and relapse still lead to and fatal disease in nearly…
Aileen Rowan
After completing a PhD in Immunology at Trinity College Dublin, I moved to Imperial College London to study how persistent infection with a virus caus…
Detection and treatment of Adult T cell leukemia/lymphoma in the premalignant stage.
Clonally expanded T cells carrying somatic mutations circulate in the premalignant phase of Adult T cell leukemia/lymphoma (ATL). We will develop of …
The Leukemia & Lymphoma Society Launches First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
The global leader in the fight against blood cancers, The Leukemia & Lymphoma Society (LLS), announced the launch of its Pediatric Acute Leukemia (Ped…
News Release
The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member
The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member
News Release
Precision Medicine For DNMT3A-Mutant T-cell ALL
ALL is an aggressive blood cancer with poor overall survival, high relapse rates, and significant side effects. Using primary patient samples, this …
Sigurður Kristinsson
Professor Sigurður Yngvi Kristinsson is currently consolidating his position as one of the leading researchers in the field of multiple myeloma, its …
Early Detection and Intervention in Smoldering Multiple Myeloma: population-based screening and treatment; Edit-SMM
We build on the success from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study, where over , consented to a nationwide screeni…
Nitin Jain
Nitin Jain, MD, is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center in Houston. He earned his medical degree from the…
Combination Targeted Therapy in Chronic Lymphocytic Leukemia
Targeted therapies have replaced chemoimmunotherapy in chronic lymphocytic leukemia (CLL). We previously reported that combined BTK inhibitor (ibrutin…
Nirav Shah
Nirav Shah, MD, MSHP is currently an Associate Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology, special…
Improving Bispecific CD20/CD19 CAR T-cell Therapy to Overcome Resistance Mechanisms in B-cell Malignancies
The objective of this proposal is to improve bispecific / CAR activity and persistence by understanding impact of cell manufacturing parameters on fi…
Neha Mehta-Shah
Neha , MD, MSCI is an Assistant Professor of Medicine at Washington University in St. Louis where she specializes in peripheral and cutaneous lymphom…